Immunological basis of bone marrow failure after allogeneic hematopoietic stem cell transplantation

by Stavroula Masouridi-Levrat, Federico Simonetta, Yves Chalandon, Yves Chalandon
Published 2016-09-01

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients

by Léna Royston, Eva Royston, Stavroula Masouridi‐Levrat, Yves Chalandon, Christian Van Delden, Dionysios Neofytos
Published 2021-09-01

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study

by Léna Royston, Eva Royston, Stavroula Masouridi-Levrat, Nathalie Vernaz, Yves Chalandon, Christian Van Delden, Dionysios Neofytos
Published 2021-04-01

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

by Federico Simonetta, Amandine Pradier, Carine Bosshard, Stavroula Masouridi-Levrat, Carole Dantin, Aikaterini Koutsi, Yordanka Tirefort, Eddy Roosnek, Yves Chalandon
Published 2019-05-01

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation

by Amandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, Carole Dantin, Diem-Lan Vu, Marie-Céline Zanella, Elsa Boely, Caroline Tapparel, Laurent Kaiser, Yves Chalandon, Federico Simonetta, Federico Simonetta, Eddy Roosnek
Published 2020-05-01

Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study

by Olga Chatzis, Stephanie Darbre, Jérôme Pasquier, Pascal Meylan, Oriol Manuel, John David Aubert, Maja Beck-Popovic, Stavroula Masouridi-Levrat, Marc Ansari, Laurent Kaiser, Klara M. Posfay-Barbe, Sandra A. Asner
Published 2018-03-01